Abstract:
A method for testing a multiplicity of chemical entities for the ability of these chemical entities to enhance or inhibit abiological process. In one embodiment, the method comprises the steps of: (a) providing a blank matrix having at least two major surfaces, the at least two major surfaces capable of receiving assay components and chemical entities; (b) applying at least one chemical entity to at least one of the at least two major surfaces of the blank matrix, whereby an impregnated matrix is formed; (c) applying to at least one of the at least two major surfaces ofthe impregnated matrix at least one assay component required for a biological process; and (d) evaluating the ability of the at least one chemical entity to enhance or inhibit the biological process involving the at least one assaycomponent. In the preferred embodiments, a response indicative of an enhancement or an inhibition of the aforementioned biological process can be detected by a tracer, which can be introduced to the impregnated matrix as an assay component. The response so detected can be preserved in the form of an image of the at least one of the two major surfaces of the impregnated matrix.
Abstract:
A method for testing a multiplicity of chemical entities for the ability of these chemical entities to enhance or inhibit abiological process. In one embodiment, the method comprises the steps of: (a) providing a blank matrix having at least two major surfaces, the at least two major surfaces capable of receiving assay components and chemical entities; (b) applying at least one chemical entity to at least one of the at least two major surfaces of the blank matrix, whereby an impregnated matrix is formed; (c) applying to at least one of the at least two major surfaces ofthe impregnated matrix at least one assay component required for a biological process; and (d) evaluating the ability of the at least one chemical entity to enhance or inhibit the biological process involving the at least one assaycomponent. In the preferred embodiments, a response indicative of an enhancement or an inhibition of the aforementioned biological process can be detected by a tracer, which can be introduced to the impregnated matrix as an assay component. The response so detected can be preserved in the form of an image of the at least one of the two major surfaces of the impregnated matrix.
Abstract:
Compounds having formula (I) are useful for treating diseases that are prevented by or ameliorated with Interleukin-2, Interleukin-4, or Interleukin-5 production inhibitors.